Clinical Trial Update: Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities [NA]

View source ↗

Summary

This study evaluated metformin and rosiglitazone, alone or in combination, in HIV-infected patients with insulin resistance and lipodystrophy; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperinsulinemia
• Lipodystrophy

Drugs mentioned

• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Lipodystrophy | NA | Status: COMPLETED